z-logo
open-access-imgOpen Access
Prevalence of asthmatic smokers: T urkish experience ( PASTE Study)
Author(s) -
Yildiz Fusun,
Dursun Adile Berna,
Disçi Rian
Publication year - 2014
Publication title -
the clinical respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 33
eISSN - 1752-699X
pISSN - 1752-6981
DOI - 10.1111/crj.12079
Subject(s) - medicine , asthma , smoking history , outpatient clinic , population , pediatrics , environmental health
Background Although both asthma and smoking are major health problems worldwide, smokers are often excluded from asthma studies. Objectives It was aimed to verify the prevalence of asthmatic smokers in T urkey and assess the effects of smoking based on clinical parameters, exacerbations and hospitalizations because of lack of national data about the prevalence of smoking among asthmatics. Methods The study protocol was comprised of a retrospective questionnaire. The asthmatic patients were followed in the outpatient clinics of 18 tertiary hospitals selected from seven different geographical regions in T urkey. We evaluated demographic data, smoking habits, asthma‐related diseases, respiratory function and emergency visits. Results The study population included 1385 patients ( M / F : 343/1042), and the mean age was 45.1 ± 14.0 years. Current and former smoking prevalence was 11.4% and 15.1%, respectively. Smoker rates were higher in males and younger asthmatics compared with females and older asthmatics ( P  < 0.01 and P  < 0.05, respectively). Smoking history ranged from 0.20 to 90 pack‐years (the mean was 12.9), and smokers had a higher level of education compared with nonsmokers ( P  < 0.01). Socioeconomically, the most developed region had the highest rate of smoker asthmatics (33.9%; P  = 0.014). There was an increase in the number of exacerbations in smoker asthmatics during the previous year, but it was not statistically significant ( P  > 0.05). Conclusion We showed that the smoking prevalence in T urkey was lower in asthmatics (11.4%) compared with the general population (44.5%). Nevertheless, every effort should be made to encourage asthmatics to stop smoking because smoking is a modifiable risk factor for adverse asthma health outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here